Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REGORAFENIB\REGORAFENIB vs REMDESIVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

REGORAFENIB\REGORAFENIB vs REMDESIVIR: Safety Overview

Metric REGORAFENIB\REGORAFENIB REMDESIVIR
Total FAERS Reports 106 10,501
Deaths Reported 32 2,729
Death Rate 30.2% 26.0%
Hospitalizations 39 2,556
Average Patient Age 60.5 yrs 61.7 yrs
% Female Patients 41.5% 39.8%
FDA Approval Date N/A Oct 22, 2020
Manufacturer N/A Gilead Sciences, Inc.
Route N/A INTRAVENOUS
Marketing Status N/A Prescription